Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fundación Mundo Sano is a private non-profit foundation dedicated to reducing the impact of neglected tropical diseases (NTDs) through scientific research, field interventions, and public-private partnerships. Founded in 1993 and led by Dr. Silvia Gold, the organization focuses on diseases such as Chagas, Dengue, and soil-transmitted helminthiasis, primarily in Latin America, Europe, and Africa. A landmark achievement for the foundation was spearheading the efforts to ensure the production and FDA approval of benznidazole, the first-line treatment for Chagas disease. The foundation works closely with academic institutions and international health organizations to translate scientific evidence into effective public health policies. By fostering multi-sector collaborations, Mundo Sano aims to improve healthcare access and quality of life for vulnerable populations affected by infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fundación Mundo Sano.